Component
Orthosilicic acid / Si(OH)4
Context-specific entity; species, compartment and exposure are stated on each claim.
27 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Orthosilicic acid in water did not significantly increase endogenous aluminum excretion over 32 hours in five volunteers.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Water dosing, small human kinetic study.
- limitations
- Different matrix, baseline aluminum and timing may matter; urinary output is not a measurement of brain aluminum.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A separate human study did not reproduce increased aluminum clearance.
- primary_references
- Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10612067/ · DOI 10.1016/s0162-0134(99)00126-9
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 112–118
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Water dosing, small human kinetic study. · source_derived_draft · unverified_draft
## silica-aluminum-urine-null A separate human study did not reproduce increased aluminum clearance. Orthosilicic acid in water did not significantly increase endogenous aluminum excretion over 32 hours in five volunteers. Model: Water dosing, small human kinetic study. Limitations: Different matrix, baseline aluminum and timing may matter; urinary output is not a measurement of brain aluminum. Evidence access: Primary abstract Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10612067/ · DOI 10.1016/s0162-0134(99)00126-9
Complete structured claim and evidenceBeer-derived monosilicic acid ingestion was accompanied by increased urinary aluminum in this study.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Healthy volunteers; beverage matrix and isotope experiments.
- limitations
- Kidney-lumen complex formation and reduced reabsorption were proposed, not directly established molecular targets.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A renal effect was proposed in addition to intestinal binding.
- primary_references
- The role of silicic acid in the renal excretion of aluminium. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8726215/
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 104–110
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Healthy volunteers; beverage matrix and isotope experiments. · source_derived_draft · unverified_draft
## silica-aluminum-urine-positive A renal effect was proposed in addition to intestinal binding. Beer-derived monosilicic acid ingestion was accompanied by increased urinary aluminum in this study. Model: Healthy volunteers; beverage matrix and isotope experiments. Limitations: Kidney-lumen complex formation and reduced reabsorption were proposed, not directly established molecular targets. Evidence access: Primary abstract The role of silicic acid in the renal excretion of aluminium. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8726215/
Complete structured claim and evidenceTen micromolar orthosilicic acid increased BMP2 expression in human osteoblast-like cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human MG-63/U2-OS cell program.
- limitations
- Expression change does not identify a direct silicon receptor.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A bone-development signal increased after exposure.
- primary_references
- Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27025722/ · DOI 10.1007/s12011-016-0686-3
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 144–150
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human MG-63/U2-OS cell program. · source_derived_draft · unverified_draft
## silica-bmp-expression A bone-development signal increased after exposure. Ten micromolar orthosilicic acid increased BMP2 expression in human osteoblast-like cells. Model: Human MG-63/U2-OS cell program. Limitations: Expression change does not identify a direct silicon receptor. Evidence access: Primary abstract Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27025722/ · DOI 10.1007/s12011-016-0686-3
Complete structured claim and evidenceOrthosilicic acid at 10–20 micromolar increased type I collagen synthesis in human osteoblast-like cultures.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- MG-63, HCC1 and primary human marrow-derived osteoblast-like cells.
- limitations
- Cell-culture synthesis is not demonstrated human bone strength or fracture benefit.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Bone-forming cells produced more collagen scaffold.
- primary_references
- Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12633784/ · DOI 10.1016/s8756-3282(02)00950-x
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 120–126
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · MG-63, HCC1 and primary human marrow-derived osteoblast-like cells. · source_derived_draft · unverified_draft
## silica-collagen-production Bone-forming cells produced more collagen scaffold. Orthosilicic acid at 10–20 micromolar increased type I collagen synthesis in human osteoblast-like cultures. Model: MG-63, HCC1 and primary human marrow-derived osteoblast-like cells. Limitations: Cell-culture synthesis is not demonstrated human bone strength or fracture benefit. Evidence access: Primary abstract Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12633784/ · DOI 10.1016/s8756-3282(02)00950-x
Complete structured claim and evidenceType I collagen mRNA did not increase despite greater collagen synthesis in treated MG-63 cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human osteosarcoma-derived MG-63 cells.
- limitations
- Translation, processing and turnover were not all separately resolved.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The measured effect was not simply more collagen-gene transcription.
- primary_references
- Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12633784/ · DOI 10.1016/s8756-3282(02)00950-x
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 128–134
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteosarcoma-derived MG-63 cells. · source_derived_draft · unverified_draft
## silica-collagen-transcript-null The measured effect was not simply more collagen-gene transcription. Type I collagen mRNA did not increase despite greater collagen synthesis in treated MG-63 cells. Model: Human osteosarcoma-derived MG-63 cells. Limitations: Translation, processing and turnover were not all separately resolved. Evidence access: Primary abstract Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12633784/ · DOI 10.1016/s8756-3282(02)00950-x
Complete structured claim and evidenceThirty micromolar OSA improved HUVEC proliferation, migration and tube formation under high glucose.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human HUVEC high-glucose model.
- limitations
- Clinical diabetic wound efficacy is unestablished; accessed abstract lacks full dose-response and inhibitor details.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A recent study tested an additional stress context.
- primary_references
- Orthosilicic Acid Promotes Diabetic Wound Healing Through the PI3 K/AKT/mTOR Signaling Pathway. · 2026 · https://pubmed.ncbi.nlm.nih.gov/40517214/ · DOI 10.1007/s12011-025-04670-6
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 336–342
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human HUVEC high-glucose model. · source_derived_draft · unverified_draft
## silica-diabetic-endothelium A recent study tested an additional stress context. Thirty micromolar OSA improved HUVEC proliferation, migration and tube formation under high glucose. Model: Human HUVEC high-glucose model. Limitations: Clinical diabetic wound efficacy is unestablished; accessed abstract lacks full dose-response and inhibitor details. Evidence access: Primary abstract Orthosilicic Acid Promotes Diabetic Wound Healing Through the PI3 K/AKT/mTOR Signaling Pathway. · 2026 · https://pubmed.ncbi.nlm.nih.gov/40517214/ · DOI 10.1007/s12011-025-04670-6
Complete structured claim and evidenceOSA improved skin-wound healing in db/db mice, with PI3K/Akt/mTOR involvement reported.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Diabetic db/db mice; primary abstract.
- limitations
- Route, formulation and complete mediation experiments require full-text follow-up; not human treatment evidence.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The research included an animal wound outcome.
- primary_references
- Orthosilicic Acid Promotes Diabetic Wound Healing Through the PI3 K/AKT/mTOR Signaling Pathway. · 2026 · https://pubmed.ncbi.nlm.nih.gov/40517214/ · DOI 10.1007/s12011-025-04670-6
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 344–350
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Diabetic db/db mice; primary abstract. · source_derived_draft · unverified_draft
## silica-diabetic-mouse-wound The research included an animal wound outcome. OSA improved skin-wound healing in db/db mice, with PI3K/Akt/mTOR involvement reported. Model: Diabetic db/db mice; primary abstract. Limitations: Route, formulation and complete mediation experiments require full-text follow-up; not human treatment evidence. Evidence access: Primary abstract Orthosilicic Acid Promotes Diabetic Wound Healing Through the PI3 K/AKT/mTOR Signaling Pathway. · 2026 · https://pubmed.ncbi.nlm.nih.gov/40517214/ · DOI 10.1007/s12011-025-04670-6
Complete structured claim and evidenceOrthosilicic acid increased miR-146a during later osteogenic differentiation of human mesenchymal stromal cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human MSC microarray and qPCR experiments.
- limitations
- Late-stage association is distinct from identification of the upstream silicon sensor.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A regulatory RNA connects exposure to cell-state change.
- primary_references
- Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27163405/ · DOI 10.1016/j.actbio.2016.05.007
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 184–190
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human MSC microarray and qPCR experiments. · source_derived_draft · unverified_draft
## silica-mir146a A regulatory RNA connects exposure to cell-state change. Orthosilicic acid increased miR-146a during later osteogenic differentiation of human mesenchymal stromal cells. Model: Human MSC microarray and qPCR experiments. Limitations: Late-stage association is distinct from identification of the upstream silicon sensor. Evidence access: Primary abstract Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27163405/ · DOI 10.1016/j.actbio.2016.05.007
Complete structured claim and evidenceThe monomeric preparation did not significantly reduce aluminum availability in the same study.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Same three-person human tracer experiment.
- limitations
- Chemical-form difference is not a scientific contradiction.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Soluble monomers and oligomers do not behave identically.
- primary_references
- Oligomeric but not monomeric silica prevents aluminum absorption in humans. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10731501/ · DOI 10.1093/ajcn/71.4.944
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 96–102
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Same three-person human tracer experiment. · source_derived_draft · unverified_draft
## silica-monomer-aluminum-null Soluble monomers and oligomers do not behave identically. The monomeric preparation did not significantly reduce aluminum availability in the same study. Model: Same three-person human tracer experiment. Limitations: Chemical-form difference is not a scientific contradiction. Evidence access: Primary abstract Oligomeric but not monomeric silica prevents aluminum absorption in humans. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10731501/ · DOI 10.1093/ajcn/71.4.944
Complete structured claim and evidenceOrthosilicic acid attenuated TNF-induced NF-kappaB activation in the osteoblast experimental program.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human MSC/mouse preosteoblast study; exact species for each downstream assay unresolved in accessed abstract.
- limitations
- Do not assign all downstream experiments to human cells or infer an oral anti-inflammatory treatment.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A regulatory-RNA response was linked to lower inflammatory signaling.
- primary_references
- Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27163405/ · DOI 10.1016/j.actbio.2016.05.007
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 520–526
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human MSC/mouse preosteoblast study; exact species for each downstream assay unresolved in accessed abstract. · source_derived_draft · unverified_draft
## silica-nfkb-regulation A regulatory-RNA response was linked to lower inflammatory signaling. Orthosilicic acid attenuated TNF-induced NF-kappaB activation in the osteoblast experimental program. Model: Human MSC/mouse preosteoblast study; exact species for each downstream assay unresolved in accessed abstract. Limitations: Do not assign all downstream experiments to human cells or infer an oral anti-inflammatory treatment. Evidence access: Primary abstract Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27163405/ · DOI 10.1016/j.actbio.2016.05.007
Complete structured claim and evidenceMedian minimum uptake estimated from urine was 50.3% in eight volunteers receiving orthosilicic acid.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Water containing 27–55 mg Si/L; small human kinetic study.
- limitations
- Urinary recovery is a lower-bound estimate, not direct intracellular measurement.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A substantial fraction of soluble silicon entered the body.
- primary_references
- Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10612067/ · DOI 10.1016/s0162-0134(99)00126-9
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 64–70
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Water containing 27–55 mg Si/L; small human kinetic study. · source_derived_draft · unverified_draft
## silica-oral-uptake A substantial fraction of soluble silicon entered the body. Median minimum uptake estimated from urine was 50.3% in eight volunteers receiving orthosilicic acid. Model: Water containing 27–55 mg Si/L; small human kinetic study. Limitations: Urinary recovery is a lower-bound estimate, not direct intracellular measurement. Evidence access: Primary abstract Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10612067/ · DOI 10.1016/s0162-0134(99)00126-9
Complete structured claim and evidenceAt 1,700 micromolar orthosilicic acid, Saos-2 colony survival was about 20% below control, with reduced proliferation/adhesion.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like culture comparison, up to solubility limit.
- limitations
- Different concentration and endpoints from low-dose collagen studies; not a fabricated contradiction.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Higher exposure was not uniformly beneficial.
- primary_references
- Divergent effects of orthosilicic acid and dimethylsilanediol on cell survival and adhesion in human osteoblast-like cells. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18755397/ · DOI 10.1016/j.jtemb.2008.02.001
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 200–206
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like culture comparison, up to solubility limit. · source_derived_draft · unverified_draft
## silica-osa-high-exposure Higher exposure was not uniformly beneficial. At 1,700 micromolar orthosilicic acid, Saos-2 colony survival was about 20% below control, with reduced proliferation/adhesion. Model: Human osteoblast-like culture comparison, up to solubility limit. Limitations: Different concentration and endpoints from low-dose collagen studies; not a fabricated contradiction. Evidence access: Primary abstract Divergent effects of orthosilicic acid and dimethylsilanediol on cell survival and adhesion in human osteoblast-like cells. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18755397/ · DOI 10.1016/j.jtemb.2008.02.001
Complete structured claim and evidenceOrthosilicic acid increased PI3K, phosphorylated Akt and mTOR together with osteogenic markers.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cell study.
- limitations
- No direct binding target or dietary requirement is established.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A growth-related pathway accompanied matrix production.
- primary_references
- Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 168–174
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cell study. · source_derived_draft · unverified_draft
## silica-pi3k-mtor A growth-related pathway accompanied matrix production. Orthosilicic acid increased PI3K, phosphorylated Akt and mTOR together with osteogenic markers. Model: Human osteoblast-like cell study. Limitations: No direct binding target or dietary requirement is established. Evidence access: Primary abstract Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
Complete structured claim and evidenceReported silicon renal clearance was 82–96 mL/min and correlated with creatinine clearance.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Healthy volunteer kinetics.
- limitations
- No universal tissue sufficiency threshold follows from serum or urine silicon.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Kidney function affects measured silicon handling.
- primary_references
- Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10612067/ · DOI 10.1016/s0162-0134(99)00126-9
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 72–78
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Healthy volunteer kinetics. · source_derived_draft · unverified_draft
## silica-renal-clearance Kidney function affects measured silicon handling. Reported silicon renal clearance was 82–96 mL/min and correlated with creatinine clearance. Model: Healthy volunteer kinetics. Limitations: No universal tissue sufficiency threshold follows from serum or urine silicon. Evidence access: Primary abstract Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10612067/ · DOI 10.1016/s0162-0134(99)00126-9
Complete structured claim and evidenceOrthosilicic acid increased phosphorylated SMAD1/5 and RUNX2 expression alongside osteogenic markers.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cell lines, 10 micromolar exposure.
- limitations
- Marker regulation does not prove each edge by direct binding.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The response extended to downstream bone-development regulators.
- primary_references
- Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27025722/ · DOI 10.1007/s12011-016-0686-3
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 152–158
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cell lines, 10 micromolar exposure. · source_derived_draft · unverified_draft
## silica-smad-runx2 The response extended to downstream bone-development regulators. Orthosilicic acid increased phosphorylated SMAD1/5 and RUNX2 expression alongside osteogenic markers. Model: Human osteoblast-like cell lines, 10 micromolar exposure. Limitations: Marker regulation does not prove each edge by direct binding. Evidence access: Primary abstract Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27025722/ · DOI 10.1007/s12011-016-0686-3
Complete structured claim and evidence
What acts on it
Expression of human AQP10 increased silicon transport in the tested oocyte and HEK-293 systems.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human constructs in Xenopus oocytes and human HEK-293 cells.
- limitations
- Expression-system flux does not establish the dominant transporter in every human tissue.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- AQP10 provides a separately identifiable route for soluble silicon.
- primary_references
- Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
- transport_effect
- raises Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
- transport_pool
- the expressing cell Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 40–46
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human constructs in Xenopus oocytes and human HEK-293 cells. · source_derived_draft · unverified_draft
## silica-aqp10-transport AQP10 provides a separately identifiable route for soluble silicon. Expression of human AQP10 increased silicon transport in the tested oocyte and HEK-293 systems. Model: Human constructs in Xenopus oocytes and human HEK-293 cells. Limitations: Expression-system flux does not establish the dominant transporter in every human tissue. Evidence access: Primary full text Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
Complete structured claim and evidenceExpression of human AQP3 increased silicon transport in the tested oocyte and HEK-293 systems.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human constructs in Xenopus oocytes and human HEK-293 cells.
- limitations
- Expression-system flux does not establish the dominant transporter in every human tissue.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- AQP3 provides a separately identifiable route for soluble silicon.
- primary_references
- Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
- transport_effect
- raises Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
- transport_pool
- the expressing cell Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 16–22
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human constructs in Xenopus oocytes and human HEK-293 cells. · source_derived_draft · unverified_draft
## silica-aqp3-transport AQP3 provides a separately identifiable route for soluble silicon. Expression of human AQP3 increased silicon transport in the tested oocyte and HEK-293 systems. Model: Human constructs in Xenopus oocytes and human HEK-293 cells. Limitations: Expression-system flux does not establish the dominant transporter in every human tissue. Evidence access: Primary full text Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
Complete structured claim and evidenceExpression of human AQP7 increased silicon transport in the tested oocyte and HEK-293 systems.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human constructs in Xenopus oocytes and human HEK-293 cells.
- limitations
- Expression-system flux does not establish the dominant transporter in every human tissue.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- AQP7 provides a separately identifiable route for soluble silicon.
- primary_references
- Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
- transport_effect
- raises Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
- transport_pool
- the expressing cell Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 24–30
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human constructs in Xenopus oocytes and human HEK-293 cells. · source_derived_draft · unverified_draft
## silica-aqp7-transport AQP7 provides a separately identifiable route for soluble silicon. Expression of human AQP7 increased silicon transport in the tested oocyte and HEK-293 systems. Model: Human constructs in Xenopus oocytes and human HEK-293 cells. Limitations: Expression-system flux does not establish the dominant transporter in every human tissue. Evidence access: Primary full text Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
Complete structured claim and evidenceExpression of human AQP9 increased silicon transport in the tested oocyte and HEK-293 systems.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human constructs in Xenopus oocytes and human HEK-293 cells.
- limitations
- Expression-system flux does not establish the dominant transporter in every human tissue.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- AQP9 provides a separately identifiable route for soluble silicon.
- primary_references
- Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
- transport_effect
- raises Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
- transport_pool
- the expressing cell Expression increased silicon transport in the oocyte and HEK-293 uptake systems.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 32–38
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human constructs in Xenopus oocytes and human HEK-293 cells. · source_derived_draft · unverified_draft
## silica-aqp9-transport AQP9 provides a separately identifiable route for soluble silicon. Expression of human AQP9 increased silicon transport in the tested oocyte and HEK-293 systems. Model: Human constructs in Xenopus oocytes and human HEK-293 cells. Limitations: Expression-system flux does not establish the dominant transporter in every human tissue. Evidence access: Primary full text Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
Complete structured claim and evidence
Where it participates (unsigned role)
Combined AQP3/AQP7/AQP9/AQP10 RNA interference reduced silicon efflux from preloaded HEK-293 cells.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human HEK-293 cells, 2 mM loading and brief efflux assay.
- limitations
- Combined knockdown does not quantify each channel’s independent in-vivo contribution.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Loss of transport machinery changes silicon movement.
- primary_references
- Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 48–54
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human HEK-293 cells, 2 mM loading and brief efflux assay. · source_derived_draft · unverified_draft
## silica-aqp-silencing Loss of transport machinery changes silicon movement. Combined AQP3/AQP7/AQP9/AQP10 RNA interference reduced silicon efflux from preloaded HEK-293 cells. Model: Human HEK-293 cells, 2 mM loading and brief efflux assay. Limitations: Combined knockdown does not quantify each channel’s independent in-vivo contribution. Evidence access: Primary full text Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
Complete structured claim and evidencePhloretin increased AQP9-mediated silicon influx under the tested hypoosmolar conditions while inhibiting water transport.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human AQP9 in Xenopus oocytes; 0.1 mM phloretin, 2 mM silicic acid.
- limitations
- Not a demonstrated food interaction; the abstract’s phloretin-sensitive wording does not mean silicon flux was inhibited.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A transport inhibitor can affect two substrates differently.
- primary_references
- Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 56–62
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human AQP9 in Xenopus oocytes; 0.1 mM phloretin, 2 mM silicic acid. · source_derived_draft · unverified_draft
## silica-aqp9-phloretin A transport inhibitor can affect two substrates differently. Phloretin increased AQP9-mediated silicon influx under the tested hypoosmolar conditions while inhibiting water transport. Model: Human AQP9 in Xenopus oocytes; 0.1 mM phloretin, 2 mM silicic acid. Limitations: Not a demonstrated food interaction; the abstract’s phloretin-sensitive wording does not mean silicon flux was inhibited. Evidence access: Primary full text Aquaporins Mediate Silicon Transport in Humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26313002/ · DOI 10.1371/journal.pone.0136149
Complete structured claim and evidenceDimethylsilanediol had no discernible survival effect up to 50 micromolar and increased survival at higher tested doses.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cell comparison.
- limitations
- Environmental silicone degradation product, not evidence that silicone polymers or supplements share this activity.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- An organosilicon compound produced a different cellular response.
- primary_references
- Divergent effects of orthosilicic acid and dimethylsilanediol on cell survival and adhesion in human osteoblast-like cells. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18755397/ · DOI 10.1016/j.jtemb.2008.02.001
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 208–214
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cell comparison. · source_derived_draft · unverified_draft
## silica-dimethyl-form An organosilicon compound produced a different cellular response. Dimethylsilanediol had no discernible survival effect up to 50 micromolar and increased survival at higher tested doses. Model: Human osteoblast-like cell comparison. Limitations: Environmental silicone degradation product, not evidence that silicone polymers or supplements share this activity. Evidence access: Primary abstract Divergent effects of orthosilicic acid and dimethylsilanediol on cell survival and adhesion in human osteoblast-like cells. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18755397/ · DOI 10.1016/j.jtemb.2008.02.001
Complete structured claim and evidenceUrinary recovery was approximately 43% for orthosilicic acid, 17% for choline-stabilized acid and 1% for colloidal silica in this comparison.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Small crossover comparisons; colloidal silica n=3, other sources at least five.
- limitations
- Different preparations and dissolution; not proof that choline itself suppresses absorption or defines a cofactor.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The same elemental amount need not deliver the same soluble exposure.
- primary_references
- The comparative absorption of silicon from different foods and food supplements. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19356271/ · DOI 10.1017/S0007114509311757
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 80–86
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Small crossover comparisons; colloidal silica n=3, other sources at least five. · source_derived_draft · unverified_draft
## silica-formulation-absorption The same elemental amount need not deliver the same soluble exposure. Urinary recovery was approximately 43% for orthosilicic acid, 17% for choline-stabilized acid and 1% for colloidal silica in this comparison. Model: Small crossover comparisons; colloidal silica n=3, other sources at least five. Limitations: Different preparations and dissolution; not proof that choline itself suppresses absorption or defines a cofactor. Evidence access: Primary abstract The comparative absorption of silicon from different foods and food supplements. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19356271/ · DOI 10.1017/S0007114509311757
Complete structured claim and evidenceProlyl hydroxylase inhibitors abolished the orthosilicic-acid-associated collagen increase.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cell inhibitor study.
- limitations
- Does not prove direct silicon binding or silicon as an obligatory enzyme cofactor.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Intact collagen-processing machinery was needed for the response.
- primary_references
- Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12633784/ · DOI 10.1016/s8756-3282(02)00950-x
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 136–142
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cell inhibitor study. · source_derived_draft · unverified_draft
## silica-hydroxylase-block Intact collagen-processing machinery was needed for the response. Prolyl hydroxylase inhibitors abolished the orthosilicic-acid-associated collagen increase. Model: Human osteoblast-like cell inhibitor study. Limitations: Does not prove direct silicon binding or silicon as an obligatory enzyme cofactor. Evidence access: Primary abstract Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12633784/ · DOI 10.1016/s8756-3282(02)00950-x
Complete structured claim and evidenceLY294002 reduced pathway signals and osteogenic markers during orthosilicic acid treatment.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cultures.
- limitations
- LY294002 has off-target effects and is not an inhibitor specific to the entire PI3K–Akt–mTOR chain.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The cell response was sensitive to PI3K-pathway blockade.
- primary_references
- Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 176–182
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cultures. · source_derived_draft · unverified_draft
## silica-ly294002-block The cell response was sensitive to PI3K-pathway blockade. LY294002 reduced pathway signals and osteogenic markers during orthosilicic acid treatment. Model: Human osteoblast-like cultures. Limitations: LY294002 has off-target effects and is not an inhibitor specific to the entire PI3K–Akt–mTOR chain. Evidence access: Primary abstract Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30421162/ · DOI 10.1007/s12011-018-1574-9
Complete structured claim and evidenceAnti-miR-146a suppressed differentiation in MC3T3 preosteoblasts in the silicate study.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mouse MC3T3 cells; distinguish from the human MSC discovery assay.
- limitations
- Abstract does not resolve all species-specific downstream targets.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Removing a regulatory RNA weakened bone-cell maturation.
- primary_references
- Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27163405/ · DOI 10.1016/j.actbio.2016.05.007
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 192–198
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse MC3T3 cells; distinguish from the human MSC discovery assay. · source_derived_draft · unverified_draft
## silica-mouse-antimir Removing a regulatory RNA weakened bone-cell maturation. Anti-miR-146a suppressed differentiation in MC3T3 preosteoblasts in the silicate study. Model: Mouse MC3T3 cells; distinguish from the human MSC discovery assay. Limitations: Abstract does not resolve all species-specific downstream targets. Evidence access: Primary abstract Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27163405/ · DOI 10.1016/j.actbio.2016.05.007
Complete structured claim and evidenceNoggin pretreatment suppressed silicon-associated SMAD1/5 phosphorylation, RUNX2 and collagen expression.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human osteoblast-like cell pharmacological experiment.
- limitations
- Noggin is a BMP antagonist, not a uniquely selective proof of BMP2 mediation.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- Blocking BMP signaling weakened the response.
- primary_references
- Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27025722/ · DOI 10.1007/s12011-016-0686-3
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 160–166
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human osteoblast-like cell pharmacological experiment. · source_derived_draft · unverified_draft
## silica-noggin-block Blocking BMP signaling weakened the response. Noggin pretreatment suppressed silicon-associated SMAD1/5 phosphorylation, RUNX2 and collagen expression. Model: Human osteoblast-like cell pharmacological experiment. Limitations: Noggin is a BMP antagonist, not a uniquely selective proof of BMP2 mediation. Evidence access: Primary abstract Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27025722/ · DOI 10.1007/s12011-016-0686-3
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.